CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure
Titel:
CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure
Auteur:
Masini, C. Vitale, M.G. Maruzzo, M. Procopio, G. De Giorgi, U. Buti, S. Rossetti, S. Iacovelli, R. Guida, A. Atzori, F. Mucciarini, C. Cosmai, L. Vignani, F. Prati, G. Scagliarini, S. Berselli, A. Pinto, C.